Banco De Sabadell, S.A Biogen Inc. Transaction History

Banco De Sabadell, S.A

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $3.47 Million - $4.01 Million	-13,113 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $938,935 - $1.24 Million	-3,630 Reduced 21.68%	13,113 $3.46 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $982,109 - $1.25 Million	-3,653 Reduced 17.91%	16,743 $5.26 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $4.49 Million - $6.2 Million	20,396 New	20,396 $6.05 Million
Q3 2019 Nov 15, 2019	SELL	$217.44 - $243.88 $5.22 Million - $5.86 Million	-24,008 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $5.26 Million - $5.8 Million	24,008 New	24,008 $5.62 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $5.93 Million - $9.28 Million	-27,368 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1.87 Million - $2.37 Million	6,730 Added 32.61%	27,368 $8.14 Million
Q3 2018 Nov 16, 2018	SELL	$293.51 - $383.83 $1.27 Million - $1.66 Million	-4,315 Reduced 17.29%	20,638 $7.32 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $139,833 - $166,652	543 Added 2.22%	24,953 $7.22 Million
Q1 2018 May 16, 2018	BUY	$260.13 - $367.91 $583,731 - $825,590	2,244 Added 10.12%	24,410 $6.55 Million
Q4 2017 Feb 16, 2018	BUY	$307.64 - $344.58 $6.82 Million - $7.64 Million	22,166	22,166 $7.06 Million

1,014

127M

1.77M

2.34M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

Stay updated on Banco De Sabadell, S.A with notifications on news.